BioRestorative Therapies Inc (BRTX) is a Healthcare · Biotechnology company listed on NASDAQ. Price $2.73 (+2.82%), Market cap $0.00B, 52-week low–high $0.17 ~ $2.00.
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells
Financial statements, price targets, institutional (13F) holdings and related news for BioRestorative Therapies Inc are updated in real time on BlackAll Trade.
BioRestorative Therapies Inc trades at $2.73 (+2.82%). Real-time quotes and charts are available on BlackAll Trade.
BioRestorative Therapies Inc has a market cap of about $0.00B.
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the tr